BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3012005)

  • 21. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic studies in chronic hemodialysis patients with hemofiltration/ultrafiltration.
    Chen WT; Chaignon M; Omvik P; Tarazi RC; Bravo EL; Nakamoto S
    Trans Am Soc Artif Intern Organs; 1978; 24():682-6. PubMed ID: 716078
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma digitalislike activity in essential hypertension or end-stage renal disease.
    Deray G; Pernollet MG; Devynck MA; Zingraff J; Touam A; Rosenfeld J; Meyer P
    Hypertension; 1986 Jul; 8(7):632-8. PubMed ID: 3013777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hemodialysis on the transport of sodium in erythrocytes from chronic renal failure patients maintained on hemodialysis.
    Gambhir KK; Parui R; Agarwal V; Cruz I
    Life Sci; 2002 Aug; 71(14):1615-21. PubMed ID: 12137908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy.
    Baldamus CA; Ernst W; Frei U; Koch KM
    Nephron; 1982; 31(4):324-32. PubMed ID: 7177269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of the sodium-potassium pump and values of sodium and potassium in erythrocytes in patients with non-dialyzed renal failure and arterial hypertension treated conservatively].
    Czarkowski M; Jabłońska-Skwiecińska E; Drygieniec D; Wardyn K; Rojek-Trebicka J; Chodakowska J
    Pol Arch Med Wewn; 1991 Dec; 86(6):341-5. PubMed ID: 1668126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte sodium transport in chronic renal failure.
    Swaminathan R; Clegg G; Cumberbatch M; Zareian Z; McKenna F
    Clin Sci (Lond); 1982 May; 62(5):489-94. PubMed ID: 6280920
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemodialysis/hemofiltration: a report of a controlled cross-over study.
    Baldamus CA; Knobloch M; Schoeppe ; Koch KM
    Int J Artif Organs; 1980 Jul; 3(4):211-4. PubMed ID: 6997218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hemodialysis on red blood cell Na+-K+-ATPase activity in terminal renal failure.
    Zannad F; Kessler M; Royer RJ; Robert J
    Nephron; 1985; 40(1):127-8. PubMed ID: 2987715
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term follow up in chronic hemofiltration.
    Quellhorst E
    Int J Artif Organs; 1983 May; 6(3):115-20. PubMed ID: 6874123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose tolerance and erythrocyte insulin receptors in undialyzed patients and patients on maintenance hemodialysis and hemofiltration.
    Kishimoto T; Ezaki K; Yamagami S; Maekawa M
    Contrib Nephrol; 1982; 32():97-110. PubMed ID: 6751689
    [No Abstract]   [Full Text] [Related]  

  • 32. Concept of natriuretic hormone.
    de Wardener HE; Clarkson EM
    Physiol Rev; 1985 Jul; 65(3):658-759. PubMed ID: 2989958
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of hemodialysis on the erythrocytes of human donor blood].
    Verkhovskiĭ BD; Krymaskiĭ LD; Shanoian SA; Rybanov AG; Abramova NV
    Probl Gematol Pereliv Krovi; 1976; 21(9):33-6. PubMed ID: 1005388
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure to show a temperature-dependent vascular stability during hemofiltration.
    Schaefer K; von Herrath D; Hüfler M
    Int J Artif Organs; 1983 Mar; 6(2):75-6. PubMed ID: 6840895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of rheomacrodex as fluid expander in repeated hemodialysis with the coil kidney].
    Ringoir S
    Acta Anaesthesiol Belg; 1968; 19(2):179-82. PubMed ID: 5746327
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythrocyte sodium-potassium activities, plasma natriuretic activity, and peripheral vascular resistances during hemodialysis or hemofiltration.
    Krzesinski JM; Godon JP; Rorive GL
    J Clin Hypertens; 1985 Sep; 1(3):245-56. PubMed ID: 3012005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstraton of a role of physical factors as determinants of the natriuretic response to volume expansion.
    Martino JA; Earley LE
    J Clin Invest; 1967 Dec; 46(12):1963-78. PubMed ID: 6074001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.